A detailed history of Oaktree Fund Advisors, LLC transactions in Alvotech stock. As of the latest transaction made, Oaktree Fund Advisors, LLC holds 118,744 shares of ALVO stock, worth $1.41 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
118,744
Previous 118,744 -0.0%
Holding current value
$1.41 Million
Previous $1.44 Million 2.08%
% of portfolio
1.83%
Previous 1.63%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$11.4 - $14.51 $197,299 - $251,124
-17,307 Reduced 12.72%
118,744 $1.44 Million
Q1 2024

May 14, 2024

SELL
$11.36 - $17.27 $4.41 Million - $6.7 Million
-387,864 Reduced 74.03%
136,051 $1.66 Million
Q4 2023

Feb 13, 2024

BUY
$8.55 - $11.48 $450,260 - $604,559
52,662 Added 11.17%
523,915 $6.01 Million
Q3 2023

Nov 13, 2023

SELL
$8.12 - $10.07 $2.87 Million - $3.55 Million
-352,944 Reduced 42.82%
471,253 $4.3 Million
Q2 2023

Aug 11, 2023

SELL
$6.9 - $13.85 $1.8 Million - $3.61 Million
-260,720 Reduced 24.03%
824,197 $6.38 Million
Q1 2023

May 15, 2023

BUY
$10.01 - $14.03 $4.18 Million - $5.86 Million
417,550 Added 62.57%
1,084,917 $14 Million
Q2 2022

Aug 15, 2022

BUY
$8.21 - $11.19 $5.48 Million - $7.47 Million
667,367 New
667,367 $5.48 Million

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $2.96B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Oaktree Fund Advisors, LLC Portfolio

Follow Oaktree Fund Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oaktree Fund Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oaktree Fund Advisors, LLC with notifications on news.